EP3202417A4 - Vaccine pharmaceutical composition for transdermal administration - Google Patents

Vaccine pharmaceutical composition for transdermal administration Download PDF

Info

Publication number: EP3202417A4
Authority: EP; European Patent Office
Prior art keywords: pharmaceutical composition; transdermal administration; vaccine pharmaceutical; vaccine; transdermal
Prior art date: 2014-10-02
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

EP15846575.7A

Other languages

German (de)

French (fr)

Other versions

EP3202417A1 (en

Inventor

Takuya Shishido

Daisuke Asari

Kyohei Matsushita

Katsuyuki Okubo

Mitsuhiko Hori

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Nitto Denko Corp

Original Assignee

Nitto Denko Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2014-10-02

Filing date

2015-10-01

Publication date

2018-04-25

2015-10-01 Application filed by Nitto Denko Corp filed Critical Nitto Denko Corp

2017-08-09 Publication of EP3202417A1 publication Critical patent/EP3202417A1/en

2018-04-25 Publication of EP3202417A4 publication Critical patent/EP3202417A4/en

Status Ceased legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Mycology (AREA)
Immunology (AREA)
Microbiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Virology (AREA)
Oncology (AREA)
Dermatology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicinal Preparation (AREA)

EP15846575.7A 2014-10-02 2015-10-01 Vaccine pharmaceutical composition for transdermal administration Ceased EP3202417A4 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2014204020		2014-10-02
PCT/JP2015/077921 WO2016052698A1 (en)	2014-10-02	2015-10-01	Vaccine pharmaceutical composition for transdermal administration

Publications (2)

Publication Number	Publication Date
EP3202417A1 EP3202417A1 (en)	2017-08-09
EP3202417A4 true EP3202417A4 (en)	2018-04-25

Family

ID=55630719

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP15846575.7A Ceased EP3202417A4 (en)	2014-10-02	2015-10-01	Vaccine pharmaceutical composition for transdermal administration

Country Status (10)

Country	Link
US (1)	US10420837B2 (en)
EP (1)	EP3202417A4 (en)
JP (1)	JP2016074654A (en)
KR (1)	KR20170055487A (en)
CN (1)	CN106714827A (en)
BR (1)	BR112017006599A2 (en)
CA (1)	CA2960940A1 (en)
RU (1)	RU2017115114A (en)
TW (1)	TW201618790A (en)
WO (1)	WO2016052698A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2016052698A1 (en) *	2014-10-02	2016-04-07	日東電工株式会社	Vaccine pharmaceutical composition for transdermal administration
JP6995468B2 (en) *	2016-08-30	2022-01-14	有限会社バイオメディカルリサーチグループ	Damshidin inducer
JP6998133B2 (en) *	2017-05-28	2022-01-18	自然免疫制御技術研究組合	Brain function improving agents, foods and pharmaceuticals using lipopolysaccharide
CN110960675B (en) *	2019-12-17	2024-02-06	天康生物制药有限公司	Navel patch vaccine for preventing and controlling diarrhea of piglets and preparation method thereof
JP7414385B1 (en)	2023-04-24	2024-01-16	源一郎杣	Lipopolysaccharide, lipopolysaccharide production method, and lipopolysaccharide formulation

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2762154A2 (en) *	2013-02-05	2014-08-06	Nitto Denko Corporation	Vaccine composition for transdermal administration
EP2762152A1 (en) *	2013-02-05	2014-08-06	Nitto Denko Corporation	WT1 peptide cancer vaccine composition for transdermal administration

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2849950B2 (en) *	1990-11-30	1999-01-27	日東電工株式会社	Transdermal formulation
CA2363146A1 (en) *	1999-02-22	2000-08-31	Solomon Langermann	Caulobacter lps immunoadjuvant
GB0103169D0 (en) *	2001-02-08	2001-03-28	Smithkline Beecham Biolog	Vaccine composition
WO2005027964A1 (en) *	2003-09-15	2005-03-31	Id Biomedical Corporation Of Quebec	Measles subunit vaccine
US20070243132A1 (en) *	2005-12-22	2007-10-18	Apollo Life Sciences Limited	Transdermal delivery of pharmaceutical agents
US20100136092A1 (en) *	2007-03-01	2010-06-03	Shinsaku Nakagawa	Transdermal immune preparation, method for production of the same, and transdermal immunization method using the same
US20090010998A1 (en) *	2007-07-03	2009-01-08	Marchitto Kevin S	Drug-delivery patch comprising a dissolvable layer and uses thereof
JP5190628B2 (en)	2008-03-31	2013-04-24	一般財団法人阪大微生物病研究会	New vaccine containing mixed immunostimulant
JP5841433B2 (en) *	2012-01-11	2016-01-13	日東電工株式会社	Intraoral film-form base and preparation
JP5650780B2 (en)	2012-04-04	2015-01-07	日東電工株式会社	Vaccine composition
CN103961701B (en) *	2013-02-05	2018-09-14	日东电工株式会社	Vaccine composition
CN103961696A (en) *	2013-02-05	2014-08-06	日东电工株式会社	Vaccine composition for transdermal administration
JP6512569B2 (en) *	2013-02-05	2019-05-15	日東電工株式会社	WT1 peptide cancer vaccine tape for transdermal administration
CN103961307B (en) *	2013-02-05	2019-11-29	日东电工株式会社	For percutaneous administration of with WT1 peptide cancer vaccine composition
CA2840954A1 (en) *	2013-02-05	2014-08-05	Nitto Denko Corporation	Vaccine composition for transdermal or mucosal administration
RU2014102941A (en) *	2013-02-05	2015-08-10	Нитто Денко Корпорейшн	Vaccine composition for administration through the mucous membrane
US10017545B2 (en) *	2013-06-03	2018-07-10	University Of Maryland, College Park	Compositions and vaccines comprising vesicles and methods of using the same
RU2016109368A (en) *	2013-10-03	2017-11-10	Нитто Денко Корпорейшн	Mucosal Vaccine Composition
CA2923026A1 (en) *	2013-10-03	2015-04-09	Nitto Denko Corporation	Nasal mucosal vaccine composition
CN105555308A (en) *	2013-10-03	2016-05-04	日东电工株式会社	Mucosal vaccine composition
WO2015050181A1 (en) *	2013-10-03	2015-04-09	日東電工株式会社	Injectable vaccine composition
US10369219B2 (en) *	2014-08-04	2019-08-06	Nitto Denko Corporation	Composition for enhancing induction of humoral immunity, and vaccine pharmaceutical composition
JP6574556B2 (en) *	2014-08-27	2019-09-11	日東電工株式会社	Intraoral film-form base and preparation
US10925936B2 (en) *	2014-09-03	2021-02-23	Nitto Denko Corporation	Vaccine pharmaceutical composition for cell-mediated immunity containing bisphosphonates
WO2016052698A1 (en) *	2014-10-02	2016-04-07	日東電工株式会社	Vaccine pharmaceutical composition for transdermal administration
JP2016210771A (en) *	2015-05-01	2016-12-15	日東電工株式会社	Allergy vaccine composition
US11278616B2 (en) *	2015-08-06	2022-03-22	Nitto Denko Corporation	Immunity induction promoting composition, and vaccine pharmaceutical composition
WO2017090766A1 (en) *	2015-11-27	2017-06-01	日東電工株式会社	Vaccine pharmaceutical composition for oral administration and method for manufacturing vaccine pharmaceutical composition for oral administration

2015
- 2015-10-01 WO PCT/JP2015/077921 patent/WO2016052698A1/en active Application Filing
- 2015-10-01 US US15/514,868 patent/US10420837B2/en not_active Expired - Fee Related
- 2015-10-01 JP JP2015195689A patent/JP2016074654A/en active Pending
- 2015-10-01 CA CA2960940A patent/CA2960940A1/en not_active Abandoned
- 2015-10-01 BR BR112017006599A patent/BR112017006599A2/en not_active Application Discontinuation
- 2015-10-01 EP EP15846575.7A patent/EP3202417A4/en not_active Ceased
- 2015-10-01 KR KR1020177007133A patent/KR20170055487A/en not_active Withdrawn
- 2015-10-01 RU RU2017115114A patent/RU2017115114A/en unknown
- 2015-10-01 TW TW104132439A patent/TW201618790A/en unknown
- 2015-10-01 CN CN201580052013.6A patent/CN106714827A/en active Pending

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2762154A2 (en) *	2013-02-05	2014-08-06	Nitto Denko Corporation	Vaccine composition for transdermal administration
EP2762152A1 (en) *	2013-02-05	2014-08-06	Nitto Denko Corporation	WT1 peptide cancer vaccine composition for transdermal administration

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
DIMITRIOS G. KOUTSONANOS ET AL: "Transdermal Influenza Immunization with Vaccine-Coated Microneedle Arrays", PLOS ONE, vol. 4, no. 3, 10 March 2009 (2009-03-10), pages e4773, XP055458799, DOI: 10.1371/journal.pone.0004773 *
KEVIN E KNOCKENHAUER ET AL: "Protective antigen composite nanofibers as a transdermal anthrax vaccine", ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, 2008. EMBS 2008. 30TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE, IEEE, PISCATAWAY, NJ, USA, 20 August 2008 (2008-08-20), pages 1040 - 1043, XP031508138, ISBN: 978-1-4244-1814-5 *
M KAZUHIKO: "Development of Transcutaneous Vaccination System for Infectious Disease Counterm easure", YAKUGAKU ZASSHI, vol. 132, no. 12, 1 January 2012 (2012-01-01), pages 1443 - 1450, XP055425297 *
MASAHIRO FUKASAKA ET AL: "A Lipopolysaccharide from Pantoea Agglomerans Is a Promising Adjuvant for Sublingual Vaccines to Induce Systemic and Mucosal Immune Responses in Mice via TLR4 Pathway", PLOS ONE, vol. 10, no. 5, 15 May 2015 (2015-05-15), pages e0126849, XP055458803, DOI: 10.1371/journal.pone.0126849 *
SACHIKO HIROBE ET AL: "Clinical study of transcutaneous vaccination using a hydrogel patch for tetanus and diphtheria", VACCINE, ELSEVIER, AMSTERDAM, NL, vol. 30, no. 10, 27 December 2011 (2011-12-27), pages 1847 - 1854, XP028462233, ISSN: 0264-410X, [retrieved on 20120102], DOI: 10.1016/J.VACCINE.2011.12.130 *
SANG-MOO KANG ET AL: "Microneedle and mucosal delivery of influenza vaccines", EXPERT REVIEW OF VACCINES, vol. 11, no. 5, 1 May 2012 (2012-05-01), GB, pages 547 - 560, XP055458800, ISSN: 1476-0584, DOI: 10.1586/erv.12.25 *
See also references of WO2016052698A1 *
SKOUNTZOU ET AL: "Transcutaneous immunization with inactivated influenza virus induces protective immune responses", VACCINE, ELSEVIER, AMSTERDAM, NL, vol. 24, no. 35-36, 28 August 2006 (2006-08-28), pages 6110 - 6119, XP005595402, ISSN: 0264-410X, DOI: 10.1016/J.VACCINE.2006.05.014 *

Also Published As

Publication number	Publication date
BR112017006599A2 (en)	2017-12-19
WO2016052698A1 (en)	2016-04-07
CA2960940A1 (en)	2016-04-07
JP2016074654A (en)	2016-05-12
TW201618790A (en)	2016-06-01
US10420837B2 (en)	2019-09-24
KR20170055487A (en)	2017-05-19
EP3202417A1 (en)	2017-08-09
CN106714827A (en)	2017-05-24
RU2017115114A (en)	2018-11-05
US20170216431A1 (en)	2017-08-03

Publication	Publication Date	Title
HK1245625A1 (en)	2018-08-31	Methods and formulations for transdermal administration
EP3102190A4 (en)	2017-09-06	Novel pharmaceutical formulations
DK3236943T3 (en)	2023-04-11	COMPOSITIONS FOR ILEO-JEJUNAL DRUG ADMINISTRATION
EP3129028A4 (en)	2017-12-06	Pharmaceutical compositions
EP3253382A4 (en)	2018-10-31	Pharmaceutical compositions for combination therapy
IL252893B (en)	2021-03-25	Pharmaceutical dosage form for application to mucous membranes
EP3199161A4 (en)	2018-04-11	Pharmaceutical preparation
EP3160491A4 (en)	2018-01-17	Pharmaceutical compositions
EP3233081A4 (en)	2018-07-04	Transdermal drug delivery device including fentanyl
EP3263155A4 (en)	2018-08-22	Drug solution administering device
HK1231390A1 (en)	2017-12-22	Pharmaceutical composition for topical administration
ZA201703562B (en)	2018-11-28	Pharmaceutical composition for oral administration comprising taxane
EP3116489A4 (en)	2018-02-21	Methods and compositions for transdermal delivery
AU2016218074B2 (en)	2020-01-30	Pharmaceutical formulation
EP3199175A4 (en)	2018-05-23	Pharmaceutical composition for injection
EP3141243A4 (en)	2017-11-22	Pharmaceutical composition
EP3238730A4 (en)	2018-10-10	Pharmaceutical preparation of camptothecin-containing polymer derivative
EP3200877A4 (en)	2018-05-23	Low dose oral pharmaceutical composition of isotretinoin
EP3202417A4 (en)	2018-04-25	Vaccine pharmaceutical composition for transdermal administration
HK1245646A1 (en)	2018-08-31	Pharmaceutical composition for oral administration
EP3351286A4 (en)	2019-05-01	Device for administering drug solution
EP3251721A4 (en)	2018-11-07	Transdermal administration device
EP3189852A4 (en)	2018-02-14	Bisphosphonate-containing pharmaceutical vaccine composition for humoral immunity
EP3095453A4 (en)	2017-09-06	Topical agent for transdermal administration
EP3107532A4 (en)	2017-07-26	Transdermal drug delivery system containing donepezil

Legal Events

Date	Code	Title	Description
2017-03-21	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE
2017-07-07	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2017-07-07	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE
2017-08-09	17P	Request for examination filed	Effective date: 20170316
2017-08-09	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2017-08-09	AX	Request for extension of the european patent	Extension state: BA ME
2018-01-10	DAV	Request for validation of the european patent (deleted)
2018-01-10	DAX	Request for extension of the european patent (deleted)
2018-04-25	A4	Supplementary search report drawn up and despatched	Effective date: 20180323
2018-04-25	RIC1	Information provided on ipc code assigned before grant	Ipc: A61P 35/00 20060101ALI20180319BHEP Ipc: A61K 39/39 20060101ALI20180319BHEP Ipc: A61K 9/70 20060101ALI20180319BHEP Ipc: A61K 39/00 20060101AFI20180319BHEP Ipc: A61K 39/02 20060101ALI20180319BHEP Ipc: A61P 31/00 20060101ALI20180319BHEP Ipc: A61K 39/12 20060101ALI20180319BHEP Ipc: A61P 37/04 20060101ALI20180319BHEP
2020-08-20	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: EXAMINATION IS IN PROGRESS
2020-09-23	17Q	First examination report despatched	Effective date: 20200819
2020-12-18	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: EXAMINATION IS IN PROGRESS
2023-05-21	REG	Reference to a national code	Ref country code: DE Ref legal event code: R003
2023-08-25	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED
2023-09-27	18R	Application refused	Effective date: 20230521